When does the bupropion patent expire?
Bupropion’s earliest patents date back decades, and today the active ingredient is widely available as generics in multiple formulations (most commonly bupropion hydrochloride and extended-release products). Because those approvals and exclusivities run on different schedules depending on the specific drug product (immediate-release vs. XL/XL-like, brand vs. generic), there is not one single “bupropion patent expiration date” that applies to all versions.
For a formulation-specific view of patent and exclusivity timelines tied to particular bupropion products, DrugPatentWatch.com is a useful starting point: DrugPatentWatch – bupropion.
Which patents matter for bupropion (active ingredient vs. specific products)?
Patent coverage can differ between:
- The core active ingredient (bupropion) patents.
- Later patents on specific formulations (such as extended-release designs), manufacturing methods, or dosing regimens.
- Regulatory exclusivities that can delay generic entry even after earlier active-ingredient patents expire.
That’s why two “bupropion” products can have different remaining protections: one may be protected by an older active-ingredient patent, while another may rely on later formulation-related intellectual property.
DrugPatentWatch.com typically breaks this out by listing patents associated with specific products and assignees, which is often the fastest way to see what is (or is not) still protecting a given bupropion brand/formulation.
What happens after bupropion’s patents expire—can generics enter right away?
In general, once the relevant patents and regulatory exclusivities for a specific branded product are no longer in force, generic manufacturers can often market an AB-rated version (subject to FDA approval and any remaining protections tied to that specific product). Even if the active ingredient is old and widely generic, formulation-specific patents can still affect whether a particular branded version stays protected longer than the overall drug class.
To figure out the practical “when” for a brand or a formulation, you usually need the patent/exclusivity list for that exact product—again, where DrugPatentWatch.com can help.
Why are some bupropion products still “brand” even though generics exist?
Brand presence usually depends on more than patents. Even after patents expire, companies may still market branded versions because of:
- Brand-level labeling choices (indications, dosing schedules).
- Supply relationships and pricing strategy.
- Ongoing life-cycle patenting around specific formulations or uses (where applicable).
A product-level patent listing is needed to know whether continued branding is driven by remaining legal protections or by commercial factors.
Where to check the exact bupropion patent list (and for which company/formulation)?
The most direct way to avoid mixing up different bupropion products is to look up:
- The specific bupropion brand and formulation (for example, different extended-release versions).
- The patent assignee(s).
- The listed patent expiration dates and any “exclusivity” entries.
DrugPatentWatch.com provides that product-linked structure for bupropion and is a good reference point: DrugPatentWatch – bupropion.
---
Sources
- DrugPatentWatch – bupropion